(Reuters) – SoftBank on Monday led a new funding round of $165 million in California-based Karius and invested $100 million in New York-headquartered AI company Behavox, as the technology giant builds a portfolio under its second Vision Fund.
FILE PHOTO: The logo of SoftBank Group Corp is displayed at SoftBank World 2017 conference in Tokyo, Japan, July 20, 2017. REUTERS/Issei Kato/File Photo/File Photo
The two deals come at a time of intense investor scrutiny into SoftBank’s investments.
The Japanese company earlier this month reported a second straight quarter of losses at its first Vision Fund, pushing Chief Executive Officer Masayoshi Son to scale back his second fund.
Karius, which markets a test that can quickly detect hard-to-diagnose infections through a simple taking of blood, said the funding would expand its commercial outreach and clinical research.
Although relatively small by the standards of Softbank (9984.T), the funding marks the latest in a list of healthcare…
Source Reuters Tech News
Source link
